Back to News
Market Impact: 0.15
Polyrizon Files New U.S. Patent Application Covering Nasal Drug Delivery
Source: Nasdaq
Patents & Intellectual PropertyTechnology & Innovation
Polyrizon Ltd. filed a new U.S. divisional patent application with the U.S. Patent and Trademark Office, expanding its intellectual property portfolio around its proprietary mucoadhesive technology. The report provided no financial figures or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
PLRZ0.45
More News
- Samsung, SK Hynix shares drop as Q3 earnings loom
- DeepSeek set to raise at least $12 bln in Tencent, CATL-led round- Bloomberg
- Security researcher claims to they found KVM guest-host escape flaw
- Brazil Election: Bolsonaro Pushes Lula to Brink as Markets Set to Rally
- SpaceX stock climbs to highest since June, returning Musk to trillionaire status
- Security researcher claims they found KVM guest-host escape flaw